LOX and neoplasm: These results are in good agreement with a previous study (22) indicating that under hypoxic conditions LOX is an intermediate signaling molecule linking HIF-1α to adherens junction molecule E-cadherin whose reduction is a characteristic feature of cells that have gone through an epithelial-to-mesenchymal transition and widely believed to amplify tumor invasiveness and progression.